HZNP

Horizon Therapeutics Public Limited Company Ordinary Shares

Delisted

HZNP was delisted on the 5th of October, 2023.

234 hedge funds and large institutions have $2.26B invested in Horizon Therapeutics Public Limited Company Ordinary Shares in 2016 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 73 increasing their positions, 82 reducing their positions, and 46 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

11% less repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 82

11% less capital invested

Capital invested by funds: $2.54B → $2.26B (-$279M)

Holders
234
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$253M
Puts
$87.1M
Net Calls
Net Calls Change

Top Buyers

1 +$131M
2 +$53.2M
3 +$40.8M
4
JP Morgan Chase
JP Morgan Chase
New York
+$40.2M
5
CCM
Consonance Capital Management
New York
+$33.9M

Top Sellers

1 -$115M
2 -$77.1M
3 -$43.7M
4
EAM
Eagle Asset Management
Florida
-$26.5M
5
Goldman Sachs
Goldman Sachs
New York
-$18.2M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$3.49M
77
$3.46M
78
$3.4M
79
$3.25M
80
$3.24M
81
$3.17M
82
$3M
83
$2.97M
84
$2.64M
85
$2.63M
86
$2.6M
87
$2.59M
88
$2.53M
89
$2.51M
90
$2.47M
91
$2.38M
92
$2.36M
93
$2.36M
94
$2.24M
95
$2.18M
96
$2.05M
97
$1.95M
98
$1.87M
99
$1.86M
100
$1.77M